WARNING:
JavaScript is turned OFF. None of the links on this concept map will
work until it is reactivated.
If you need help turning JavaScript On, click here.
This Concept Map, created with IHMC CmapTools, has information related to: Skin Infection Efficacy Framework - v7, Percent Reduction in Lesion Size >= 20 percent measured at -Entry Visit -48 to 72 hrs from Entry, Signs and Symptoms has outcome Failure, Change in Route of Administration documented with Reason for Change in Route of Administration, Lesion Size derived from Maximum Length, Clinical Response has outcome Success, Signs and Symptoms has systemic signs and symptoms -Fever -Elevated WBC -Immature Neutrophils, Signs and Symptoms has local signs and symptoms -Erythema -Purulent Discharge/Drainage -Non-Purlent Discharge/Drainage -Swelling/Induration -Fluctuance -Tenderness to Palpation -Heat/Localized Warmth -Pain, Clinical Response assessed from Lesion Size, Complications has option -Bacteremia, Infection Type has option -Cellulitis/Erycipelas -Major Cutaneous Abscess -Wound Infection, Efficacy Endpoints has components Percent Reduction in Lesion Size >= 20 percent, Resolution of ABSSSI measured in population -ITT -microITT -Clinically Evaluable -Microbiologically Evaluable, Change in Route of Administration documented with Date of Switch, Percent Reduction in Lesion Size >= 20 percent derived from Clinical Response, Clinical Response has outcome Indeterminate, Failure documented with Failure Reason, Percent Reduction in Lesion Size >= 20 percent measured in population -ITT -microITT -Clinically Evaluable -Microbiologically Evaluable, -Erythema -Purulent Discharge/Drainage -Non-Purlent Discharge/Drainage -Swelling/Induration -Fluctuance -Tenderness to Palpation -Heat/Localized Warmth -Pain graded as -Absent -Mild -Moderate -Severe, Resolution of ABSSSI measured at -Entry Visit -7 to 14 days after completion of therapy, Resolution of ABSSSI derived from Signs and Symptoms